Jasło, Poland

Stanisław Pikul

This inventor holds 1 USPTO granted patent. Top assignee: Molecure S.a.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stanisław Pikul: Innovator in Chemical Synthesis

Introduction

Stanisław Pikul is a notable inventor based in Jasło, Poland. He has made significant contributions to the field of chemical synthesis, particularly in the development of innovative processes for producing complex compounds. His work is characterized by a focus on efficiency and the creation of valuable intermediates in pharmaceutical chemistry.

Latest Patents

Stanisław Pikul holds a patent for a process related to the synthesis of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine. This invention pertains to the production of this compound in two hydrated crystalline forms and one anhydrous crystalline form. Additionally, the patent includes the synthesis of methyl (Z)-4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)-N-cyanopiperidine-1-carbimidothioate, which serves as an intermediate in the synthesis process. He has 1 patent to his name.

Career Highlights

Stanisław Pikul is currently associated with Molecure S.A., a company that focuses on the development of innovative therapies for various diseases. His role at Molecure has allowed him to apply his expertise in chemical synthesis to real-world applications, contributing to the advancement of pharmaceutical research.

Collaborations

Throughout his career, Stanisław has collaborated with talented professionals in the field, including Grzegorz Witkowski and Marta Magdycz. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective projects.

Conclusion

Stanisław Pikul is a distinguished inventor whose work in chemical synthesis has made a notable impact in the pharmaceutical industry. His innovative processes and collaborations highlight his commitment to advancing scientific knowledge and improving therapeutic options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…